Alzheimer's disease—subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies. Issue 1 (January 2016)

• Record Type: Journal Article
• Authors: Wallin, Anders; Nordlund, Arto; Jonsson, Michael; Blennow, Kaj; Zetterberg, Henrik; Öhrfelt, Annika; Stålhammar, Jacob; Eckerström, Marie; Carlsson, Mårten; Olsson, Erik; Göthlin, Mattias; Svensson, Johan; Rolstad, Sindre; Eckerström, Carl; Bjerke, Maria
• Is Part Of: Journal of cerebral blood flow & metabolism. Volume 36:Issue 1(2016)
• Page Start: 95
• Page End: 113
• Publication Date: 2016-01
• Subjects: Alzheimer's disease -- cognitive impairment -- magnetic resonance -- neurochemistry -- neuropsychology -- subcortical vascular dementia -- white matter changes; Cerebral circulation -- Periodicals; Brain -- Metabolism -- Periodicals; Brain -- Blood-vessels -- Periodicals; Cerebrovascular disease -- Periodicals; 612.824
• DOI: 10.1038/jcbfm.2015.148
• Languages: English
• ISSNs: 0271-678X

Abstract

The ability to discriminate between Alzheimer's disease (AD), subcortical vascular disease, and other cognitive disorders is crucial for diagnostic purposes and clinical trial outcomes. Patients with primarily subcortical vascular disease are unlikely to benefit from treatments targeting the AD pathogenic mechanisms and vice versa. The Gothenburg mild cognitive impairment (MCI) and dementia studies are prospective, observational, single-center cohort studies suitable for both cross-sectional and longitudinal analysis that outline the cognitive profiles and biomarker characteristics of patients with AD, subcortical vascular disease, and other cognitive disorders. The studies, the first of which started in 1987, comprise inpatients with manifest dementia and patients seeking care for cognitive disorders at an outpatient memory clinic. This article gives an overview of the major published papers (neuropsychological, imaging/physiology, and neurochemical) of the studies including the ongoing Gothenburg MCI study. The main findings suggest that subcortical vascular disease with or without dementia exhibit a characteristic neuropsychological pattern of mental slowness and executive dysfunction and neurochemical deviations typical of white matter changes and disturbed blood–brain barrier function. Our findings may contribute to better healthcare for this underrecognized group of patients. The Gothenburg MCI study has also published papers on multimodal prediction of dementia, and cognitive reserve.